Your session is about to expire
← Back to Search
Community Health Interventions for Renal Disease (INSPIRE Trial)
N/A
Waitlist Available
Led By Lili Chan
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient must speak English and/or Spanish
Patient must be aged between 18 and 75 years
Must not have
Patient must have absolute contraindications to KTx such as self-reported or documented diagnosis of dementia, inability to understand the study and complete informed consent, active malignancy (excluding specific cases), pregnancy, or active infection
Patient must be on other types of dialysis besides in-center hemodialysis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, and then every 6 months up to 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if using community health workers and providing education to healthcare providers can help more people with kidney disease get on the transplant waiting list. The trial will compare this approach to the standard care.
Who is the study for?
This trial is for patients with renal disease who are under the care of CKD/HD providers. Participants will be grouped based on their provider's random assignment to either the intervention or control group. The study aims to help those facing social challenges that affect their health.
What is being tested?
The trial is testing if support from community health workers and additional education for kidney transplant providers can increase the number of patients getting on a transplant waitlist, compared to usual care without this extra support.
What are the potential side effects?
Since this trial involves non-medical interventions like education and community assistance rather than drugs, typical medication side effects are not expected. However, there may be indirect effects related to changes in healthcare management.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I speak English or Spanish.
Select...
I am between 18 and 75 years old.
Select...
My kidney function is very low or I am on regular dialysis.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot have a kidney transplant due to conditions like dementia, active cancer, pregnancy, or an ongoing infection.
Select...
I am on a form of dialysis that is not in-center hemodialysis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, and then every 6 months up to 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, and then every 6 months up to 2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Time to completion of kidney transplant waitlisting evaluation
Secondary study objectives
Accountable Health Communities Health-Related Social Needs Screening Tool (AHC-HRSN)
Binary outcome of patient being KTx waitlisted or not by year 1 post enrollment
Binary outcome of patient being KTx waitlisted or not by year 2 post enrollment
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment3 Interventions
Participants will receive usual care and at the end of the study will receive education, and work with CHWs in a more limited capacity. Control clinicians will receive the education intervention.
Group II: Community Health Worker and Intervention Providers-Assisted Kidney Transplant SupportExperimental Treatment2 Interventions
Participants will receive assignment to a community health worker who will educate them on the kidney transplant process, assist them through the kidney transplant process and connect them with any necessary social services.
Find a Location
Who is running the clinical trial?
Icahn School of Medicine at Mount SinaiLead Sponsor
903 Previous Clinical Trials
541,402 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,443 Previous Clinical Trials
4,330,761 Total Patients Enrolled
Lili ChanPrincipal InvestigatorIchan School of Medicine at Mount Sinai Hospital
Share this study with friends
Copy Link
Messenger